Similar results were obtained with the PHQ15, for which a highly significant difference was found in both the crude and adjusted mean scores of somatic symptoms, being higher in the nonadherent patients, at 10.39 (5.98) and 10.40 (0.88) vs. 7.69 (5.23), and 7.69 (0.38), respectively.
← all excerpts
Prevalence and biopsychosocial factors associated with treatment adherence among people with epilepsy in a tertiary care hospital in Riyadh, Saudi Arabia.
1
—
—